SciTropin A™ is recombinant human growth hormone synthesised in E. coli cells. It is identical to naturally-occurring human growth hormone. SciTropin A™ is used for the treatment of short stature in children due to growth hormone deficiency, growth disorder associated with Turner syndrome, growth disorder in short children/ adolescent born small for gestational age, Prader-Willi syndrome for improvement of growth & body composition, growth disorder associated with chronic kidney insufficiency and replacement therapy for growth hormone deficiency in Adults.

The Global Growth Hormone Market is now estimated to be at US$2.5 billion.



SciTropin A customers - Beware of imitation/ fake product.
Click here for information